Spotlight on mCRC

Welcome to the second edition of Spotlight on mCRC with: Real-world experiences in mCRC

THURSDAY, 25TH SEPTEMBER 2025 17:00-19:00 CEST – STREAMED ONLINE

Chaired by
JULIEN TAIEB
Head of the Gastroenterology and Gastrointestinal Oncology Department
Hôpital Européen Georges-Pompidou, Université de Paris, France

FACULTY

The Value of Real-World Evidence in mCRC

MIRIAM KOOPMAN
University Medical Center Utrecht Utrecht, Netherlands
MICHAEL NEUMAIER
Universitätsmedizin Mannheim Institut für Klinische Chemie Mannheim, Germany
ELENA ÉLEZ
Vall d’Hebron Institute of Oncology Barcelona, Spain

Clinical Cases in mCRC and Best Practices

MARTINA AMNITZBØLL ERIKSEN
Rigshospitalet Copenhagen, Denmark
SÉRGIO XAVIER AZEVEDO
Faculdade de Medicina da Universidade do Porto Porto, Portugal
IOANNIS SOUGLAKOS
University of Crete Crete, Greece

AGENDA

The Value of Real-World Evidence in mCRC

Welcome and Introduction Julien Taieb, Andrea Grignolio
How should real-world data from mCRC make a difference? Miriam Koopman
Real-world insights into the treatment of specific mCRC alterations Elena Élez
Using molecular biomarkers in the real world: Trends and challenges Michael Neumaier

Clinical Cases in mCRC and Best Practices

Opening and overview of the clinical cases Julien Taieb
A patient with BRAFV600E-mutant and MSI-H mCRC Martina Amnitzbøll Eriksen
A patient with KRASG12C-mutant mCRC Sérgio Xavier Azevedo
A patient with HER2 overexpression Ioannis Souglakos

Q&A Session & Closing

See detailed agenda HERE

For more information and registration